We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+7.03%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.76B
AUM Growth
-$256M
Cap. Flow
-$351M
Cap. Flow %
-19.91%
Top 10 Hldgs %
49.94%
Holding
89
New
12
Increased
13
Reduced
24
Closed
14

Top Buys

Rank Stock Value
1
ACHC icon
Acadia Healthcare
ACHC
+$19.2M
2
INSP icon
Inspire Medical Systems
INSP
+$17.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$12.3M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$12M
5
WAT icon
Waters Corp
WAT
+$9.94M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$39.7M
2
DXCM icon
DexCom
DXCM
+$26.2M
3
EW icon
Edwards Lifesciences
EW
+$25.4M
4
BSX icon
Boston Scientific
BSX
+$18.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$18.8M

Sector Composition

Rank Sector Weight
1 Healthcare 95.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
51
DELISTED
Day One Biopharmaceuticals
DAWN
$4.77M 0.27%
342,172
-54,472
-14% -$777K
CNTA
52
DELISTED
Centessa Pharmaceuticals
CNTA
$4.3M 0.24%
269,158
-366,485
-58% -$4.49M
VEEV icon
53
Veeva Systems
VEEV
$34.7B
$4.04M 0.23%
+19,259
New +$3.81M
LBPH
54
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$3.79M 0.21%
+113,711
New +$3.92M
OCUL icon
55
Ocular Therapeutix
OCUL
$1.87B
$3.5M 0.2%
+402,843
New +$3.32M
IMVT icon
56
Immunovant
IMVT
$8.06B
$3.5M 0.2%
122,701
-349,839
-74% -$10.3M
CGEM icon
57
Cullinan Oncology
CGEM
$1.08B
$3.06M 0.17%
182,810
-113,226
-38% -$2.01M
LUNG icon
58
Pulmonx
LUNG
$83.6M
$3.06M 0.17%
+368,929
New +$2.67M
PMVP icon
59
PMV Pharmaceuticals
PMVP
$62.4M
$3M 0.17%
2,011,040
+735,578
+58% +$1.14M
CMPS
60
Compass Pathways
CMPS
$1.83B
$2.84M 0.16%
451,267
-638,325
-59% -$4.5M
IOBT
61
DELISTED
IO Biotech
IOBT
$2.46M 0.14%
2,341,107
– –
CAPR icon
62
Capricor Therapeutics
CAPR
$228M
$2.32M 0.13%
+152,779
New +$756K
MGX icon
63
Metagenomi Therapeutics
MGX
$45.9M
$2.24M 0.13%
1,034,002
-233,000
-18% -$808K
ARKG icon
64
ARK Genomic Revolution ETF
ARKG
$1.66B
$2.23M 0.13%
+86,934
New +$2.21M
INBX icon
65
Inhibrx
INBX
$1.23B
$2.12M 0.12%
135,546
– –
GBIO
66
DELISTED
Generation Bio
GBIO
$1.95M 0.11%
78,791
– –
SGMT icon
67
Sagimet Biosciences
SGMT
$534M
$1.8M 0.1%
649,006
– –
CLDX icon
68
Celldex Therapeutics
CLDX
$3.22B
$1.77M 0.1%
52,120
– –
IOVA icon
69
Iovance Biotherapeutics
IOVA
$1.94B
$1.24M 0.07%
132,152
-20,643
-14% -$196K
BOLD
70
Boundless Bio
BOLD
$62.9M
$835K 0.05%
240,513
+100,000
+71% +$362K
VERV
71
DELISTED
Verve Therapeutics
VERV
$610K 0.03%
+125,999
New +$732K
QURE icon
72
uniQure
QURE
$3.07B
$600K 0.03%
121,628
-152,912
-56% -$996K
TSBX
73
DELISTED
Turnstone Biologics
TSBX
$519K 0.03%
932,348
– –
APLS
74
DELISTED
Apellis Pharmaceuticals
APLS
– –
-82,952
Closed -$3.18M
CNC icon
75
Centene
CNC
$33.1B
– –
-598,513
Closed -$39.7M
1 2
3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

PFM Health Sciences's Q3 2024 Portfolio in Review

As of Q3 2024, PFM Health Sciences held 89 positions worth $1.76B, down 13% from $2.02B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

PFM Health Sciences withdrew a net $351M in Q3 2024, closing 14 positions and reducing 24 holdings. Its most notable exit was Centene, an estimated $39.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 89% a quarter earlier.

Against the trend, PFM Health Sciences opened a new position in Inspire Medical Systems worth $20.8M.

  • PFM Health Sciences's largest Q3 2024 buy was Inspire Medical Systems: 98,322 shares worth $20.8M.
  • PFM Health Sciences added most to Acadia Healthcare in Q3 2024, an estimated $19.2M increase.
  • PFM Health Sciences's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $25.4M.
  • PFM Health Sciences fully exited Centene in Q3 2024, selling an estimated $39.7M.
  • PFM Health Sciences's ten largest holdings make up 50% of its $1.76B portfolio in Q3 2024.
  • PFM Health Sciences opened 12 new positions and closed 14 in Q3 2024.
  • PFM Health Sciences's portfolio value fell 13% quarter-over-quarter to $1.76B.

Based on PFM Health Sciences's 13F filing for Q3 2024, filed 14 Nov 2024.